Literature DB >> 18852270

KPC-2-producing Enterobacter cloacae and pseudomonas putida coinfection in a liver transplant recipient.

Jason W Bennett1, Monica L Herrera, James S Lewis, Brian W Wickes, James H Jorgensen.   

Abstract

Carbapenemases are among the newest resistance mechanisms to emerge in some gram-negative bacteria. We describe bacteremia in a critically ill liver transplant recipient infected with KPC-2-producing Enterobacter cloacae and Pseudomonas putida. Although this enzyme has been previously described in Enterobacter spp., this is the first report of KPC carbapenemase in P. putida.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18852270      PMCID： PMC2612145          DOI： 10.1128/AAC.00931-08

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  13 in total

1.  Design and evaluation of PCR primers to amplify bacterial 16S ribosomal DNA fragments used for community fingerprinting.

Authors:  K Watanabe; Y Kodama; S Harayama
Journal:  J Microbiol Methods       Date:  2001-04       Impact factor: 2.363

2.  First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase.

Authors:  Maria Virginia Villegas; Karen Lolans; Adriana Correa; Juan Nicolas Kattan; Jaime A Lopez; John P Quinn
Journal:  Antimicrob Agents Chemother       Date:  2007-01-29       Impact factor: 5.191

Review 3.  Carbapenemases: the versatile beta-lactamases.

Authors:  Anne Marie Queenan; Karen Bush
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

4.  Characterization of an integron carrying blaIMP-1 and a new aminoglycoside resistance gene, aac(6')-31, and its dissemination among genetically unrelated clinical isolates in a Brazilian hospital.

Authors:  Rodrigo E Mendes; Mariana Castanheira; Mark A Toleman; Helio S Sader; Ronald N Jones; Timothy R Walsh
Journal:  Antimicrob Agents Chemother       Date:  2007-04-30       Impact factor: 5.191

5.  Nosocomial infections caused by multidrug-resistant Pseudomonas putida isolates producing VIM-2 and VIM-4 metallo-beta-lactamases.

Authors:  Pierre Bogaerts; Te-Din Huang; Hector Rodriguez-Villalobos; Caroline Bauraing; Ariane Deplano; Marc J Struelens; Youri Glupczynski
Journal:  J Antimicrob Chemother       Date:  2008-01-31       Impact factor: 5.790

6.  Mechanisms of resistance to fluoroquinolones and carbapenems in Pseudomonas putida.

Authors:  Toshinobu Horii; Hideaki Muramatsu; Yoshitsugu Iinuma
Journal:  J Antimicrob Chemother       Date:  2005-07-26       Impact factor: 5.790

7.  Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program.

Authors:  Mariana Castanheira; Hélio S Sader; Lalitagauri M Deshpande; Thomas R Fritsche; Ronald N Jones
Journal:  Antimicrob Agents Chemother       Date:  2007-12-10       Impact factor: 5.191

8.  First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.

Authors:  James S Lewis; Monica Herrera; Brian Wickes; Jan E Patterson; James H Jorgensen
Journal:  Antimicrob Agents Chemother       Date:  2007-08-27       Impact factor: 5.191

9.  Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae.

Authors:  K F Anderson; D R Lonsway; J K Rasheed; J Biddle; B Jensen; L K McDougal; R B Carey; A Thompson; S Stocker; B Limbago; J B Patel
Journal:  J Clin Microbiol       Date:  2007-06-20       Impact factor: 5.948

10.  VIM-2-producing Pseudomonas putida, Buenos Aires.

Authors:  Marisa Almuzara; Marcela Radice; Natalia de Gárate; Alejandra Kossman; Arabela Cuirolo; Gisela Santella; Angela Famiglietti; Gabriel Gutkind; Varolos Vay
Journal:  Emerg Infect Dis       Date:  2007-04       Impact factor: 6.883
View more
  24 in total

1.  First description of KPC-2-producing Pseudomonas putida in Brazil.

Authors:  Anna C S Almeida; Marinalda A Vilela; Felipe L S Cavalcanti; Willames M B S Martins; Marcos A Morais; Marcia M C Morais
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

2.  Detection of colonization by carbapenemase-producing Gram-negative Bacilli in patients by use of the Xpert MDRO assay.

Authors:  Fred C Tenover; Rafael Canton; JoAnn Kop; Ryan Chan; Jamie Ryan; Fred Weir; Patricia Ruiz-Garbajosa; Vincent LaBombardi; David H Persing
Journal:  J Clin Microbiol       Date:  2013-09-04       Impact factor: 5.948

Review 3.  Carbapenem-resistant Enterobacteriaceae in special populations: Solid organ transplant recipients, stem cell transplant recipients, and patients with hematologic malignancies.

Authors:  Stephanie M Pouch; Michael J Satlin
Journal:  Virulence       Date:  2016-07-28       Impact factor: 5.882

4.  Characterization of ertapenem-resistant Enterobacter cloacae in a Taiwanese university hospital.

Authors:  Fu-Chen Yang; Jing-Jou Yan; Kuei-Hsiang Hung; Jiunn-Jong Wu
Journal:  J Clin Microbiol       Date:  2011-11-30       Impact factor: 5.948

Review 5.  Screening for carbapenem-resistant Enterobacteriaceae: Who, When, and How?

Authors:  Sandra S Richter; Dror Marchaim
Journal:  Virulence       Date:  2016-11-04       Impact factor: 5.882

6.  Inhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase.

Authors:  Krisztina M Papp-Wallace; Christopher R Bethel; Anne M Distler; Courtney Kasuboski; Magdalena Taracila; Robert A Bonomo
Journal:  Antimicrob Agents Chemother       Date:  2009-12-14       Impact factor: 5.191

7.  Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India.

Authors:  Dongeun Yong; Mark A Toleman; Christian G Giske; Hyun S Cho; Kristina Sundman; Kyungwon Lee; Timothy R Walsh
Journal:  Antimicrob Agents Chemother       Date:  2009-09-21       Impact factor: 5.191

8.  The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignancies.

Authors:  Michael J Satlin; Stephen G Jenkins; Thomas J Walsh
Journal:  Clin Infect Dis       Date:  2014-01-23       Impact factor: 9.079

9.  Novel genetic environment of the carbapenem-hydrolyzing beta-lactamase KPC-2 among Enterobacteriaceae in China.

Authors:  Ping Shen; Zeqing Wei; Yan Jiang; Xiaoxing Du; Shujuan Ji; Yunsong Yu; Lanjuan Li
Journal:  Antimicrob Agents Chemother       Date:  2009-07-20       Impact factor: 5.191

Review 10.  Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases.

Authors:  L Silvia Munoz-Price; Laurent Poirel; Robert A Bonomo; Mitchell J Schwaber; George L Daikos; Martin Cormican; Giuseppe Cornaglia; Javier Garau; Marek Gniadkowski; Mary K Hayden; Karthikeyan Kumarasamy; David M Livermore; Juan J Maya; Patrice Nordmann; Jean B Patel; David L Paterson; Johann Pitout; Maria Virginia Villegas; Hui Wang; Neil Woodford; John P Quinn
Journal:  Lancet Infect Dis       Date:  2013-09       Impact factor: 25.071
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.